Comparative efficacy and safety and dolutegravir and lamivudine in treatment naive HIV patients

OBJECTIVE: Compare the efficacy and safety of the 2-drug antiretroviral therapy regimen dolutegravir + lamivudine (DTG + 3TC) with traditional 3-drug regimens in treatment-naive patients with HIV-1. DESIGN: Data from double-blind, randomized controlled trials of at least 48 weeks’ duration in treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Radford, Matthew, Parks, Daniel C., Ferrante, Shannon, Punekar, Yogesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2019
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686958/
https://www.ncbi.nlm.nih.gov/pubmed/31180906
http://dx.doi.org/10.1097/QAD.0000000000002285

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686958/
https://www.ncbi.nlm.nih.gov/pubmed/31180906
http://dx.doi.org/10.1097/QAD.0000000000002285

Ejemplares similares